Clinical Laserthermia Systems AB (CLS) is a medical equipment company that develops and markets instruments for the treatment of cancer. The company offers Tranberg, a thermal therapy system developed for image guided high precision treatment of soft tissues and ablation procedures. Tranberg is approved in Europe for immune stimulating interstitial thermotherapy (imILT) treatments. CLS is also evaluating its products for treating focal laser ablation and other combined therapies. The company offers its product to hospitals and specialist clinics involved surgical oncology and oncologic interventional radiology and has operations for clinical studies in Italy, France, Germany, UK, Sweden and Portugal for different indications. CLS is headquartered Lund, Sweden.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Clinical Laserthermia Systems AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Clinical Laserthermia Systems AB Company Overview
- Clinical Laserthermia Systems AB Company Snapshot
- Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview
- Clinical Laserthermia Systems AB - Pipeline Analysis Overview
- Business Description
- Clinical Laserthermia Systems AB - Key Facts
- Clinical Laserthermia Systems AB - Major Products and Services
- Clinical Laserthermia Systems AB Pipeline Products by Development Stage
- Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
- Clinical Laserthermia Systems AB Pipeline Products Overview
- imILT Software
- imILT Software Product Overview
- MRI-Integrated Thermometry Software
- MRI-Integrated Thermometry Software Product Overview
- ThermoGuide
- ThermoGuide Product Overview
- ThermoGuide Clinical Trial
- Tranberg Cancer Immunotherapy System - Breast Cancer
- Tranberg Cancer Immunotherapy System - Breast Cancer Product Overview
- TRANBERG Cancer Immunotherapy System - Pancreatic Cancer
- TRANBERG Cancer Immunotherapy System - Pancreatic Cancer Product Overview
- TRANBERG Cancer Immunotherapy System - Skin Cancer
- TRANBERG Cancer Immunotherapy System - Skin Cancer Product Overview
- TRANBERG Cancer Immunotherapy System - Small Liver Metastases
- TRANBERG Cancer Immunotherapy System - Small Liver Metastases Product Overview
- TRANBERG Cancer Immunotherapy System - Solid Cancers
- TRANBERG Cancer Immunotherapy System - Solid Cancers Product Overview
- Tranberg CLS Thermal Therapy System
- Tranberg CLS Thermal Therapy System Product Overview
- Tranberg CLS Thermal Therapy System Clinical Trial
- Tranberg CLS Thermal Therapy System - Glioblastoma Ablation
- Tranberg CLS Thermal Therapy System - Glioblastoma Ablation Product Overview
- Tranberg CLS Thermal Therapy System - Glioblastoma Ablation Clinical Trial
- Tranberg CLS Thermal Therapy System - Prostate Cancer
- Tranberg CLS Thermal Therapy System - Prostate Cancer Product Overview
- Tranberg CLS Thermal Therapy System - Prostate Cancer Clinical Trial
- Clinical Laserthermia Systems AB - Key Competitors
- Clinical Laserthermia Systems AB - Key Employees
- Clinical Laserthermia Systems AB - Key Employee Biographies
- Clinical Laserthermia Systems AB - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Clinical Laserthermia Systems AB, Recent Developments
- Jun 29, 2023: Clinical Laserthermia Systems Notice of Annual General Meeting
- May 29, 2023: Clinical Laserthermia Systems publishes annual report 2022
- May 25, 2023: Clinical Laserthermia Systems publishes interim report January - March 2023
- May 22, 2023: CLS Appoints Executive Vice President Operations
- Feb 08, 2023: Clinical Laserthermia Systems to host Strategy Update Event on February 15
- Jan 19, 2023: Clinical Laserthermia Systems AB (publ) carries out a directed issue of shares to set-off debt following a request for loan conversion by lenders
- Nov 17, 2022: Clinical Laserthermia Systems AB publishes interim report January - September 2022
- Nov 17, 2022: Clinical Laserthermia Systems publishes interim report January - September 2022
- Sep 30, 2022: Clinical Laserthermia Systems AB announces last day of trading in BTU and first day of trading in warrants of series TO 5 B
- Aug 10, 2022: The Board of Directors of Clinical Laserthermia Systems AB (publ) resolves on a rights issue of units for an initial amount of approximately 69.3 MSEK
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Clinical Laserthermia Systems AB Pipeline Products and Ongoing Clinical Trials Overview
- Clinical Laserthermia Systems AB Pipeline Products by Equipment Type
- Clinical Laserthermia Systems AB Pipeline Products by Indication
- Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
- Clinical Laserthermia Systems AB, Key Facts
- Clinical Laserthermia Systems AB, Major Products and Services
- Clinical Laserthermia Systems AB Number of Pipeline Products by Development Stage
- Clinical Laserthermia Systems AB Pipeline Products Summary by Development Stage
- Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
- Clinical Laserthermia Systems AB Ongoing Clinical Trials Summary
- imILT Software - Product Status
- imILT Software - Product Description
- MRI-Integrated Thermometry Software - Product Status
- MRI-Integrated Thermometry Software - Product Description
- ThermoGuide - Product Status
- ThermoGuide - Product Description
- ThermoGuide - Evaluation of the Safety and Feasibility of Magnetic Resonance Guided Focused Laser Ablation for Localized Prostate Cancer in Low to Intermediate Risk Patients
- ThermoGuide - Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesion Using the Tranberg Thermal Therapy System and Tranberg Thermoguide Workstation
- Tranberg Cancer Immunotherapy System - Breast Cancer - Product Status
- Tranberg Cancer Immunotherapy System - Breast Cancer - Product Description
- TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Product Status
- TRANBERG Cancer Immunotherapy System - Pancreatic Cancer - Product Description
- TRANBERG Cancer Immunotherapy System - Skin Cancer - Product Status
- TRANBERG Cancer Immunotherapy System - Skin Cancer - Product Description
- TRANBERG Cancer Immunotherapy System - Small Liver Metastases - Product Status
- TRANBERG Cancer Immunotherapy System - Small Liver Metastases - Product Description
- TRANBERG Cancer Immunotherapy System - Solid Cancers - Product Status
- TRANBERG Cancer Immunotherapy System - Solid Cancers - Product Description
- Tranberg CLS Thermal Therapy System - Product Status
- Tranberg CLS Thermal Therapy System - Product Description
- Tranberg CLS Thermal Therapy System - A Phase II Study to Evaluate Outpatient Magnetic Resonance Image-guided Laser Focal Therapy for Prostate Cancer: A 20-year Survival Study
- Tranberg CLS Thermal Therapy System - Clinical Study for Evaluation of Safety and Efficacy of MRI-guided Laser Ablation with Tranberg Thermal Therapy System in Prostate Cancer Subjects
- Tranberg CLS Thermal Therapy System - Glioblastoma Ablation - Product Status
- Tranberg CLS Thermal Therapy System - Glioblastoma Ablation - Product Description
- Tranberg CLS Thermal Therapy System - Glioblastoma Ablation - Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesion Using the Tranberg Thermal Therapy System and Tranberg Thermoguide Workstation
- Tranberg CLS Thermal Therapy System - Prostate Cancer - Product Status
- Tranberg CLS Thermal Therapy System - Prostate Cancer - Product Description
- Tranberg CLS Thermal Therapy System - Prostate Cancer - A Post-market Study To Evaluate the Safety and Short Term Efficacy of TRANBERG Thermal Therapy System
- Tranberg CLS Thermal Therapy System - Prostate Cancer - A Study to Evaluate the Focal Laser Ablation Treatment in Patients with Localized Prostate Cancer
- Tranberg CLS Thermal Therapy System - Prostate Cancer - Evaluation of the Safety and Feasibility of Magnetic Resonance Guided Focused Laser Ablation for Localized Prostate Cancer in Low to Intermediate Risk Patients
- Tranberg CLS Thermal Therapy System - Prostate Cancer - Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging
- Tranberg CLS Thermal Therapy System - Prostate Cancer - MRI Guided Focal Laser Ablation of Prostate Cancer
- Tranberg CLS Thermal Therapy System - Prostate Cancer - TRANBERG Transperineal MR/US Focalyx Fusion Laser--Induced Thermal Therapy in the Office Setting Under Local Anesthesia
- Clinical Laserthermia Systems AB, Key Employees
- Clinical Laserthermia Systems AB, Key Employee Biographies
- Clinical Laserthermia Systems AB, Subsidiaries
- Glossary
- Clinical Laserthermia Systems AB Pipeline Products by Equipment Type
- Clinical Laserthermia Systems AB Pipeline Products by Development Stage
- Clinical Laserthermia Systems AB Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Elekta AB
- Seno Medical Instruments Inc
- SpectraCure AB
- Micropos Medical AB
- Dignitana AB
